Is MiNK Therapeutics, Inc. overvalued?

MiNK Therapeutics, Inc. (INKT) — key valuation metrics and fundamentals.

No verdict

Price

$11.27

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$56.1M

Dividend yield

0.0%

Return on equity

76.0%

Sector

Healthcare

Fair value compares INKT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks